IMPROVED OUTCOME FOR POOR-PROGNOSIS METASTATIC GERM CELL CANCER: A SINGLE CENTER EXPERIENCE IN JAPAN

被引：0
|
作者：
Yamada, Shigeyuki
Saito, Hideo
Kaiho, Yasuhiro
Ito, Akihiro
Ishidoya, Shigeto
Arai, Yoichi
机构：
来源：
JOURNAL OF UROLOGY | 2010年 / 183卷 / 04期
关键词：
D O I：
10.1016/j.juro.2010.02.2343
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
841
引用
收藏
页码：E328 / E329
页数：2
相关论文
共 50 条
  • [41] Improved survival in metastatic germ-cell cancer
    Fankhauser, C. D.
    Sander, S.
    Roth, L.
    Beyer, J.
    Hermanns, T.
    ANNALS OF ONCOLOGY, 2018, 29 (02) : 347 - 351
  • [42] PCPro: a clinically accessible, circulating lipid biomarker signature for poor-prognosis metastatic prostate cancer
    Tahlia Scheinberg
    Hui-Ming Lin
    Michael Fitzpatrick
    Arun A. Azad
    Paul Bonnitcha
    Amy Davies
    Gillian Heller
    Kevin Huynh
    Blossom Mak
    Kate Mahon
    David Sullivan
    Peter J. Meikle
    Lisa G. Horvath
    Prostate Cancer and Prostatic Diseases, 2024, 27 : 136 - 143
  • [43] PCPro: a clinically accessible, circulating lipid biomarker signature for poor-prognosis metastatic prostate cancer
    Scheinberg, Tahlia
    Lin Hui-ming
    Fitzpatrick, Michael
    Azad, Arun
    Bonnitcha, Paul
    Davies, Amy
    Heller, Gillian
    Huynh, Kevin
    Mak, Blossom
    Mahon, Kate
    Mellor, Rhiannon
    Sullivan, David
    Meikle, Peter
    Horvath, Lisa
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 : 84 - 84
  • [44] Dose-dense chemotherapy for untreated poor-prognosis and relapsed germ-cell tumours: an 18-year experience with GAMEC chemotherapy
    Shamash, Jonathan
    Mee, Matthew
    Sarker, Shah-Jalal
    Wilson, Peter
    Ansell, Wendy
    Greenwood, Michelle
    Berney, Dan
    Alifrangis, Constantine
    BJU INTERNATIONAL, 2020, 125 (06) : 843 - 852
  • [45] Navigating prognostic communication when children with poor-prognosis cancer experience prolonged disease stability
    Porter, Amy S.
    Chow, Emma
    Woods, Cameka
    Lemmon, Monica E.
    Baker, Justin N.
    Mack, Jennifer W.
    Kaye, Erica C.
    PEDIATRIC BLOOD & CANCER, 2023, 70 (01)
  • [46] Treatment outcome of patients with extragonadal nonseminomatous germ cell tumors: the Saitama Cancer Center experience
    Fukui, Naotaka
    Kohno, Yusuke
    Ishioka, Jun-Ichiro
    Fukuda, Hiroshi
    Kageyama, Yukio
    Higashi, Yotsuo
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (04) : 731 - 734
  • [47] Treatment outcome of patients with extragonadal nonseminomatous germ cell tumors: the Saitama Cancer Center experience
    Naotaka Fukui
    Yusuke Kohno
    Jun-Ichiro Ishioka
    Hiroshi Fukuda
    Yukio Kageyama
    Yotsuo Higashi
    International Journal of Clinical Oncology, 2013, 18 : 731 - 734
  • [48] Patterns of relapse in poor-prognosis germ cell tumors in the GETUG 13 trial: Implications for assessment of brain progression
    Loriot, Yohann
    Pagliaro, Lance C.
    Flechon, Aude
    Mardiak, Jozef
    Geoffrois, Lionnel
    Kerbrat, Pierre
    Chevreau, Christine
    Delva, Remy
    Rolland, Frederic
    Theodore, Christine
    Bui, Binh
    Gravis, Gwenaelle
    Eymard, Jean-Christophe
    Malhaire, Jean-Pierre
    Linassier, Claude
    Habibian, Muriel
    Logothetis, Christopher
    Culine, Stephane
    Laplanche, Agnes
    Fizazi, Karim
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [49] Mature results of the GETUG 13 phase III trial in poor-prognosis germ-cell tumors (GCT).
    Fizazi, Karim
    Flechon, Aude
    Le Teuff, Gwenael
    Mardiak, Jozef
    Pagliaro, Lance C.
    Geoffrois, Lionnel
    Kerbrat, Pierre
    Chevreau, Christine
    Delva, Remy
    Rolland, Frederic
    Theodore, Christine
    Roubaud, Guilhem
    Gravis, Gwenaelle
    Eymard, Jean-Christophe
    Malhaire, Jean-pierre
    Linassier, Claude
    Habibian, Muriel
    Reckova, Maria
    Logothetis, Christopher
    Culine, Stephane
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [50] Intermediate prognosis in metastatic germ cell tumors (IPGCT): Outcome and prognostic stratification
    Seidel, C.
    Daugaard, K. G.
    Tryakin, A.
    Necchi, A.
    Cedermark, G. Cohn
    Stahl, O.
    Hentrich, M.
    Brito, M.
    Albany, C.
    Taza, F.
    Gerl, A.
    Oechsle, K.
    Oing, C.
    Bokemeyer, C.
    ANNALS OF ONCOLOGY, 2018, 29 : 325 - 325
12345